Cambridge Investment Research Advisors, Inc. Utah Medical Products Inc Transaction History
Cambridge Investment Research Advisors, Inc.
- $29.4 Billion
- Q3 2024
A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Utah Medical Products Inc stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 3,496 shares of UTMD stock, worth $212,941. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,496
Previous 3,519
0.65%
Holding current value
$212,941
Previous $235,000
0.43%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding UTMD
# of Institutions
108Shares Held
2.11MCall Options Held
0Put Options Held
0-
Jim Simons Renaissance Technologies LLC | New York, Ny231KShares$14 Million0.02% of portfolio
-
Black Rock Inc. New York, NY197KShares$12 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA181KShares$11 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX176KShares$10.7 Million0.0% of portfolio
-
Brandes Investment Partners, LP La Jolla, CA138KShares$8.43 Million0.11% of portfolio
About UTAH MEDICAL PRODUCTS INC
- Ticker UTMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 3,625,200
- Market Cap $221M
- Description
- Utah Medical Products, Inc. develops, manufactures, and distributes medical devices for the healthcare industry. The company offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems. It also provides GESCO u...